|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/125 | (2006.01) |
| A61K 39/125 | (2013.01) | ||
| A61K2039/5258 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61K2039/55505 | (2013.01) | ||
| A61K2039/55572 | (2013.01) | ||
| A61K2039/70 | (2013.01) | ||
| C12N2770/16034 | (2013.01) | ||
| A61K 39/12 | (2013.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 37/04 | (2018.01) |
| (11) | Number of the document | 3299030 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17199372.8 |
| Date of filing the European patent application | 2012-07-11 | |
| (97) | Date of publication of the European application | 2018-03-28 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161506447 P | 2011-07-11 | US |
| (72) |
RICHARDSON, Charles , US
BARGATZE, Robert, F. , US
MENDELMAN, Paul, M. , US
|
| (73) |
Takeda Vaccines, Inc. ,
75 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | PARENTERAL NOROVIRUS VACCINE FORMULATIONS |
| PARENTERAL NOROVIRUS VACCINE FORMULATIONS |